| scholarly article | Q13442814 |
| P2093 | author name string | Tracy L Stevens | |
| William S Harris | |||
| A Michael Borkon | |||
| Anthony Magalski | |||
| Scott A Sands | |||
| Charles B Porter | |||
| Sheryl L Windsor | |||
| Hakim A Ali | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fatty acid | Q61476 |
| patient | Q181600 | ||
| P304 | page(s) | 1645-1649 | |
| P577 | publication date | 2004-09-07 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation | |
| P478 | volume | 110 |
| Q35753222 | (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? |
| Q96773869 | A New Zealand green-lipped mussel oil-enriched high-fat diet exhibits beneficial effects on body weight and metabolism in mice |
| Q36692065 | Adult medication-free schizophrenic patients exhibit long-chain omega-3 Fatty Acid deficiency: implications for cardiovascular disease risk |
| Q35918788 | Are omega-3 fatty acids the most important nutritional modulators of coronary heart disease risk? |
| Q47210384 | Association between Red Blood Cells Omega-3 Polyunsaturated Fatty Acids and White Matter Hyperintensities: The MAPT Study |
| Q88577597 | Association of oily fish intake, sex, age, BMI and APOE genotype with plasma long-chain n-3 fatty acid composition |
| Q44040735 | Associations of plasma phospholipid fatty acids with plasma homocysteine in Chinese vegetarians |
| Q33852181 | Bioavailability of Dietary Omega-3 Fatty Acids Added to a Variety of Sausages in Healthy Individuals |
| Q38202021 | Cardiac physiology and clinical efficacy of dietary fish oil clarified through cellular mechanisms of omega-3 polyunsaturated fatty acids. |
| Q40196363 | Cardioprotective effects of ω -3 PUFAs in chronic kidney disease |
| Q36030203 | Changes in erythrocyte membrane trans and marine fatty acids between 1999 and 2006 in older Americans |
| Q36859103 | Changes in plasma and erythrocyte omega-6 and omega-3 fatty acids in response to intravenous supply of omega-3 fatty acids in patients with hepatic colorectal metastases |
| Q36021903 | Circulating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study |
| Q44909920 | Comparison of the incorporation of orally administered DHA into plasma, erythrocyte and cheek cell glycerophospholipids |
| Q39588472 | Correcting the effects of -20 °C storage and aliquot size on erythrocyte fatty acid content in the Women's Health Initiative |
| Q48199137 | Cross-sectional associations of cortical β-amyloid with erythrocyte membrane long-chain polyunsaturated fatty acids in older adults with subjective memory complaints |
| Q28658910 | DHA-containing oilseed: a timely solution for the sustainability issues surrounding fish oil sources of the health-benefitting long-chain omega-3 oils |
| Q57148526 | Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline? |
| Q37445796 | Determinants of Blood Cell Omega-3 Fatty Acid Content |
| Q36913180 | Dietary arachidonic acid: harmful, harmless or helpful? |
| Q45250690 | Dietary fish oil dose- and time-response effects on cardiac phospholipid fatty acid composition |
| Q34783642 | Dietary fish oil modestly attenuates the effect of age on diastolic function but has no effect on memory or brain inflammation in aged rats |
| Q33227649 | Dietary fish oil protects against stretch-induced vulnerability to atrial fibrillation in a rabbit model |
| Q84805572 | Dietary intake of stearidonic acid–enriched soybean oil increases the omega-3 index: randomized, double-blind clinical study of efficacy and safety |
| Q38010563 | Dietary methods and biomarkers of omega 3 fatty acids: a systematic review |
| Q28235974 | Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway |
| Q35036431 | Dietary omega-3 fatty acids promote arrhythmogenic remodeling of cellular Ca2+ handling in a postinfarction model of sudden cardiac death |
| Q35000399 | Differential effects of antipsychotic medications on polyunsaturated fatty acid biosynthesis in rats: Relationship with liver delta6-desaturase expression |
| Q46846903 | Direct microwave transesterification of fingertip prick blood samples for fatty acid determinations |
| Q42486664 | Docosahexaenoic acid supplementation in vegetarians effectively increases omega-3 index: a randomized trial |
| Q46918945 | Dose-dependent effects of docosahexaenoic acid-rich fish oil on erythrocyte docosahexaenoic acid and blood lipid levels |
| Q36307290 | EPA, not DHA, prevents fibrosis in pressure overload-induced heart failure: potential role of free fatty acid receptor 4 |
| Q57734945 | Effect of Intravenous ω-3 Fatty Acid Infusion and Hemodialysis on Fatty Acid Composition of Free Fatty Acids and Phospholipids in Patients With End-Stage Renal Disease |
| Q34536010 | Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial |
| Q35056896 | Effect of dietary omega-3 fatty acids on the heart rate and the heart rate variability responses to myocardial ischemia or submaximal exercise |
| Q35855327 | Effect of dietary omega-3 polyunsaturated Fatty acids on heart rate and heart rate variability in animals susceptible or resistant to ventricular fibrillation |
| Q43085164 | Effects of a convenience drink fortified with n-3 fatty acids on the n-3 index |
| Q80184580 | Effects of arachidonate-enriched triacylglycerol supplementation on serum fatty acids and platelet aggregation in healthy male subjects with a fish diet |
| Q33784422 | Effects of dietary omega-3 fatty acids on ventricular function in dogs with healed myocardial infarctions: in vivo and in vitro studies |
| Q80688376 | Eicosapentaenoic acid for prevention of major coronary events |
| Q37815091 | Electrophysiological mechanisms of the anti-arrhythmic effects of omega-3 fatty acids |
| Q50555472 | Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters |
| Q48214983 | Evaluation of Marine Microalga Diacronema vlkianum Biomass Fatty Acid Assimilation in Wistar Rats. |
| Q36691953 | Evaluation of docosahexaenoic acid in a dog model of hypertension induced left ventricular hypertrophy. |
| Q50481453 | Fish meal supplementation and ambulatory blood pressure in patients with hypertension: relevance of baseline membrane fatty acid composition. |
| Q79566564 | Fish oil significantly alters fatty acid profiles in various lipid fractions but not atherogenesis in apo E-KO mice |
| Q37291302 | Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction |
| Q35624662 | High intake of saturated fat, but not polyunsaturated fat, improves survival in heart failure despite persistent mitochondrial defects |
| Q64900229 | Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study. |
| Q57296672 | Impact of Blood or Erythrocyte Membrane Fatty Acids for Disease Risk Prediction: Focusing on Cardiovascular Disease and Chronic Kidney Disease |
| Q34691809 | Incorporated fish oil fatty acids prevent action potential shortening induced by circulating fish oil fatty acids |
| Q36231619 | Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. |
| Q37485596 | Increased inflammation, reduced plasma phospholipid eicosapentaenoic acid and reduced antioxidant potential of treated hypertensive patients with metabolic syndrome |
| Q46620193 | Interactions of ethanol drinking with n-3 fatty acids in rats: potential consequences for the cardiovascular system |
| Q34022014 | Is the omega-3 index a valid marker of intestinal membrane phospholipid EPA+DHA content? |
| Q35761506 | Krill oil attenuates left ventricular dilatation after myocardial infarction in rats |
| Q37250773 | Limited impact of 2 g/day omega-3 fatty acid ethyl esters (Omacor®) on plasma lipids and inflammatory markers in patients awaiting carotid endarterectomy. |
| Q38825512 | Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes |
| Q54600938 | Long-chain n-3 DHA reduces the extent of skeletal muscle fatigue in the rat in vivo hindlimb model. |
| Q38432847 | Long-chain n-3 PUFA against breast and prostate cancer: Which are the appropriate doses for intervention studies in animals and humans? |
| Q79705378 | Long-chain n-3 polyunsaturated fatty acid incorporation into human atrium following fish oil supplementation |
| Q38151841 | Long-chain omega-3 fatty acids: time to establish a dietary reference intake |
| Q33902043 | Low dietary fish-oil threshold for myocardial membrane n-3 PUFA enrichment independent of n-6 PUFA intake in rats |
| Q34570897 | Low levels of the omega-3 index are associated with sudden cardiac arrest and remain stable in survivors in the subacute phase |
| Q34350376 | Lower docosahexaenoic acid concentrations in the postmortem prefrontal cortex of adult depressed suicide victims compared with controls without cardiovascular disease |
| Q35341985 | Marine fish oils are not equivalent with respect to B-cell membrane organization and activation |
| Q36528123 | Marine n3 polyunsaturated fatty acids enhance resistance to mitochondrial permeability transition in heart failure but do not improve survival |
| Q30251589 | Marine omega-3 highly unsaturated fatty acids: From mechanisms to clinical implications in heart failure and arrhythmias. |
| Q37848935 | Maternal fatty acid status during pregnancy and lactation and relation to newborn and infant status |
| Q37414767 | Membrane omega-3 Fatty Acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder |
| Q89029592 | Modification of Erythrocyte Membrane Fatty Acid Contents After Kidney Transplantation: A Prospective Study |
| Q37123712 | New evidence for the cardiovascular benefits of long chain omega-3 fatty acids |
| Q35670915 | Omega-3 Index and sudden cardiac death |
| Q46329255 | Omega-3 Index correlates with healthier food consumption in adolescents and with reduced cardiovascular disease risk factors in adolescent boys |
| Q37626547 | Omega-3 PUFA supplementation and the response to evoked endotoxemia in healthy volunteers |
| Q33723143 | Omega-3 fatty acid biomarkers and subsequent depressive symptoms |
| Q36387184 | Omega-3 fatty acid supplementation and cardiovascular disease |
| Q28570995 | Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney |
| Q35855795 | Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor |
| Q38160641 | Omega-3 fatty acids and cardiovascular disease: new developments and applications |
| Q37617749 | Omega-3 index and cardiovascular health |
| Q50458076 | Omega-3 index levels and associated factors in a middle-aged French population: the MONA LISA-NUT Study |
| Q35741991 | Pharmacokinetics of Eicosapentaenoic Acid in Plasma and Red Blood Cells After Multiple Oral Dosing With Icosapent Ethyl in Healthy Subjects |
| Q58780747 | Plasma Saturated and Monounsaturated Fatty Acids in Behçet's Disease |
| Q34522281 | Plasma and erythrocyte membrane phospholipids and fatty acids in Italian general population and hemodialysis patients |
| Q36974431 | Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study |
| Q37151032 | Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects. |
| Q40221406 | Predictors of change in omega-3 index with fish oil supplementation in peripheral artery disease |
| Q38651214 | Public health relevance of drug-nutrition interactions. |
| Q34536800 | Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3? |
| Q36012382 | Red Blood Cell Docosapentaenoic Acid (DPA n-3) is Inversely Associated with Triglycerides and C-reactive Protein (CRP) in Healthy Adults and Dose-Dependently Increases Following n-3 Fatty Acid Supplementation. |
| Q36616072 | Red blood cell fatty acid levels improve GRACE score prediction of 2-yr mortality in patients with myocardial infarction |
| Q33440563 | Red blood cell fatty acid patterns and acute coronary syndrome |
| Q40251617 | Red blood cell polyunsaturated fatty acids and mortality in the Women's Health Initiative Memory Study. |
| Q35776495 | Red blood cell ω-3 fatty acid levels and markers of accelerated brain aging. |
| Q36773267 | Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice. |
| Q39333821 | Serum lipid profile and fatty acid composition of erythrocyte phospholipids in children and adolescents with primary hyperlipidemia |
| Q55499401 | Sex Differences in Omega-3 and -6 Fatty Acids and Health Status Among Young Adults With Acute Myocardial Infarction: Results From the VIRGO Study. |
| Q50699965 | Stearidonic acid increases the red blood cell and heart eicosapentaenoic acid content in dogs. |
| Q37978843 | Stearidonic acid raises red blood cell membrane eicosapentaenoic acid |
| Q46443758 | Stearidonic acid-enriched soybean oil increased the omega-3 index, an emerging cardiovascular risk marker |
| Q33738461 | Structural equation modeling for analyzing erythrocyte fatty acids in Framingham |
| Q50099570 | The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review. |
| Q36012359 | The Pattern of Fatty Acids Displaced by EPA and DHA Following 12 Months Supplementation Varies between Blood Cell and Plasma Fractions. |
| Q35012952 | The cardioprotective effects of fish oil during pressure overload are blocked by high fat intake: role of cardiac phospholipid remodeling |
| Q43202592 | The effect of lean fish consumption on triglyceride levels |
| Q34080568 | The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxin |
| Q38683354 | The future for long chain n-3 PUFA in the prevention of coronary heart disease: do we need to target non-fish-eaters? |
| Q50760657 | The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. |
| Q44111910 | The opposite associations of long-chain versus very long-chain monounsaturated fatty acids with mortality among patients with coronary artery disease |
| Q46912892 | The percentage of n-3 highly unsaturated fatty acids in total HUFA as a biomarker for omega-3 fatty acid status in tissues |
| Q41675416 | The relation of red blood cell fatty acids with vascular stiffness, cardiac structure and left ventricular function: the Framingham Heart Study |
| Q36495874 | The role of long-chained marine N-3 polyunsaturated Fatty acids in cardiovascular disease. |
| Q28818633 | The time course of erythrocyte membrane fatty acid concentrations during and after treatment of non-human primates with increasing doses of an omega-3 rich phospholipid preparation derived from krill-oil |
| Q43500133 | Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. |
| Q37804417 | Upstream effect for atrial fibrillation: still a dilemma? |
| Q43061596 | Use of red blood cell fatty-acid profiles as biomarkers in cardiac disease |
| Q46186293 | Validation of an FFQ for evaluation of EPA and DHA intake |
| Q47642249 | Very long-chain n-3 fatty acids and human health: fact, fiction and the future |
| Q36755923 | n-3 Fatty acid fortification: opportunities and obstacles |
| Q46016227 | n-3 Fatty acid intake from marine food products among Quebecers: comparison to worldwide recommendations. |
| Q37341044 | omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential |
| Q42426614 | ω-3 Polyunsaturated fatty acids prevent pressure overload-induced ventricular dilation and decrease in mitochondrial enzymes despite no change in adiponectin |
| Q30670248 | ω-3 fatty acids and domain-specific cognitive aging: secondary analyses of data from WHISCA. |
Search more.